We report a magneto-nanosensor biochip for fungal detection. The chip is made of arrays of giant magnetoresistive (GMR) spinvalve sensors, and is able to detect protein biomarkers at low concentrations in solutions. As a demonstration, a standard curve for fungal pathogen Asp f 1 was obtained by measuring signals from various concentrations of Asp f 1 spiked in PBS solutions, indicating a detection limit of 100 pg/ml. Five positive and negative Asp f 1 solution samples were discriminated correctly in blind experiments. Our data suggest that the magneto-nanosensor biochips are very promising as sensitive diagnostic devices for fungal pathogens. Given the generality of the detection scheme used in the magneto-nanosensor, we anticipate that the platform will be very useful for the detection of many types of biomarkers.
I. INTRODUCTION

S
ENSITIVE and rapid detection of protein biomarkers is expected to play an important role in molecular diagnosis of numerous diseases as well as personalized medical treatment of patients [1] - [3] . In spite of recent advances in various detection methods, development of diagnostic tools suitable for ultra-sensitive and multiplex detection of protein biomarkers remains in its infancy stage. Magneto-nanosensor biochip, capable of multiplexed detection of up to 64 protein biomarkers, has emerged as a practical contender as a biomedical diagnostic platform [4] - [6] . Compared with non-magnetic technologies, this platform offers several advantages such as large linear dynamic range, facile integration with electronics, and enhanced signal-to-noise ratio due to ultra-sensitive GMR effect and negligible magnetic background signals from mostly non-magnetic biological species [5] . In this study, we demonstrate the feasibility of using the magneto-nanosensor biochips for the detection of Asp f 1, a major allergen of fungal pathogen Aspergillus Fumigatus, which can cause serious fungal infections in humans and animals [7] .
II. MATERIALS AND METHODS
All experiments were performed in ambient condition except the surface cleaning steps (cleaning with acetone, methanol, isopropanol, and oxygen plasma) which must be performed in a fume hood.
A. Materials
Asp f 1 enzyme-linked immunosorbent assay (ELISA) kit (Indoor biotechnologies, EL-AF1), EZ-Link micro sulfo-NHSbiotinylation kit (Thermo scientific, 21925), poly(allylamine hydrochloride) (Polyscience), poly(ethylene-alt-maleic anhydride) (Aldrich), Phosphate buffered saline (PBS) (Invitrogen), [8] .
B. Biotinylation of Detection Antibody
EZ-Link micro sulfo-NHS-biotinylation kit was used for the biotinylation of the detection antibody. First, 100 l of detection antibody solution was diluted with 100 l of PBS. Separately, 1 mg of sulfo-NHS-biotin was dissolved in 110 l of PBS, resulting in a solution of 20 mM concentration. The prepared two solutions were mixed together and incubated at room temperature for 45 minutes. Excess biotins were removed using a desalt spin column included in the kit. Prior to the removal of the excess biotins, a desalt spin column was buffer exchanged by centrifuging at 1000 g (e.g., 2500 rpm if 15 cm distant from center) for 2 minutes and centrifuging 3 times more with an addition of 1 ml of PBS for each additional step. After that, the premixed and incubated solution of the sulfo-NHS-biotin and the detection antibody was added to the buffer exchanged desalt spin column. A purified solution of biotinylated-detection antibody was obtained after the final centrifugation at 1000 g for 2 minutes.
C. Sensor Surface Preparation
The sensor chip surface was cleaned with acetone, methanol, and isopropanol. After subsequent cleaning with oxygen plasma, the sensor chip surface was coated with 1% solution of poly(allylamine hydrochloride) for 5 minutes. The chip was washed with deionized water, and then annealed at 120 C for 1 hour. Following the coating with 2% poly(ethylene-alt-maleic anhydride) solution and washing with deionized water, a 1:1 mixture solution of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide was added to activate the carboxyl groups on the biochip surface.
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D. Biochip Immunoassay Protocol
The sensor chip was taken out of the humidity chamber and washed with a washing buffer (0.1% BSA and 0.05% Tween 20 in PBS). The surface was further blocked for 1 hour using a 1% BSA solution. The surface was washed again. Following the incubation with an analyte solution of Asp f 1 for 2 hours and washing, an Asp f 1 detection antibody solution with a concentration of 10 g/ml was added. The chip was incubated for 1 hour and washed. Finally, the chip was placed in a biochip reader station with electric signal read-out capability which was implemented according to Hall et al. [9] . Signal acquisition was done in real-time with the addition of streptavidin-coated magnetic nanoparticles. The obtained signal was fitted to a double exponential curve to estimate a final value.
III. RESULTS AND DISCUSSION
The magneto-nanosensor biochip immunoassay relies on GMR spin-valve sensors to quantify the number of magnetic nanoparticle labels selectively bound to the sensor surface. We used 10 mm 12 mm-sized prototype biochips with an array of 64 individually addressable sensors (each sensor is made of 48 spin-valve strips with a size of 90 m 0.75 m) covered by ultrathin and biochemically-stable silicon oxide passivation [10] . Fig. 1 illustrates the detection scheme of the magneto-nanosensor biochip immunoassay. Capture antibodies are immobilized on the sensor surface covalently (Fig. 1(a) ) to capture Asp f 1 allergens. After Asp f 1 allergens are captured by the capture antibodies ( Fig. 1(b) ), detection antibodies are added, which bind to the allergens in the form of a sandwich structure (Fig. 1(c) ). The detection antibodies are biotinylated in advance (Section II.B), and thus they can be subsequently labeled by nm-diameter streptavidin-coated magnetic nanoparticles ( Fig. 1(d) ). Finally, the magnetic nanoparticles generate a stray magnetic field in real time and perturb the oscillating external magnetic field which is applied during the measurement. As a result of the GMR effect, the resistance of the spin-valve is changed as the magnetic nanoparticles bind to the sensor surface, which leads to the specific biological signal we measure [9] .
The measured signals are related to Asp f 1 concentrations in a manner similar to the Langmuir absorption behavior. A representative binding curve is shown in Fig. 2 , where the Asp f 1 analyte concentration is 10 ng/ml. Whereas the Asp f 1 allergen (green) gives signals around 600 ppm after 10 minute of measurement, BSA-coated negative control sensors (orange) produce very small signals because they are designed not to bind with Asp f 1 allergens or streptavidin-coated magnetic nanoparticles. These small signals measured for the BSA-coated negative control sensors are mostly originated from the insignificant but observable non-specific binding of the Asp f 1 allergens or streptavidin-coated magnetic nanoparticles. The closeness between the negative control signals and the electrical reference signals (red) indicates that the observed large signals from the Asp f 1 capture antibody-coated sensors indeed come from the specific binding of the Asp f 1 allergens to the Asp f 1 capture antibodies.
The Asp f 1 standard curve was obtained by measuring signals of spiked solutions with various Asp f 1 concentrations and subtracting the signals from BSA-coated negative control sensors (Fig. 3) . A total of seven chips were measured for 10 minutes each. The subtraction of the BSA signal was done to remove the effect of the non-specific bindings even though it was very small. The salient features of our results are: We are able to get measurable signals from the Asp f 1 solutions of concentrations down to ng/ml. This detection limit is smaller than that of commercially available ELISA kit (Indoor biotechnologies, EL-AF1) which claims a detection limit of 0.3 ng/ml. The highest signal we measured is 600 ppm for 10 ng/ml standard solution of Asp f 1, and the signals begin to saturate at higher concentrations. The linear dynamic range of the standard curve is about two orders of magnitude (from to ng/ml), which is somehow much smaller than the 4-6 logs reported previously [6] . We believe this is largely limited by the availability of high affinity reagents rather than by the magnetic sensors or nanoparticles at this point.
In separate experiments, five Asp f 1 solutions with their concentrations undisclosed to the experimenter were measured. In other words, experiments were "blinded" so that the experimenter was not aware of the real concentrations of the Asp f 1 in the solutions, and the dilution ratios were suggested to test the positive and negative responses. As can be seen in Table I , positive and negative response samples could be determined correctly using the measurement results, indicating the proper working of the magneto-nanosensor biochips.
IV. CONCLUSION
It was demonstrated that the magneto-nanosensor biochip immunoassay could be used for the quantification of Aspergillus fumigatus allergen Asp f 1 with high sensitivity. The magnetonanosensor biochip has a detection limit lower than that of the commercial ELISA kit, and is expected to be very useful for the ultra-sensitive detection of several allergic disorders and infections caused by the fungal pathogens. Taken together with previous reports [4] - [6] , this platform technology holds great potentials for biomedical diagnosis of many diseases since the detection scheme used in our study is applicable to numerous types of protein biomarkers.
